SARS-CoV-2 3CLpro-IN-19

Biorbyt

SARS-CoV-2 3CLpro-IN-19

10

Research Use Only

98.00%

C24H22ClN3O2S

451.97

SARS-CoV-2 3CLpro-IN-19 (Compound C5a), a non-covalent, non-peptide inhibitor of the SARS-CoV-2 3CLpro enzyme, exhibits potent in vitro activity with an IC50 of 0.7 microM. It demonstrates broad-spectrum efficacy against infection by Omicron subvariants (BA.5, BQ.1.1, and XBB.1.5) in human cells, with EC50 values ranging from 30-69 nM [1].

-20°C

12352200